Chapman Steven Leonard sold $1.6M of NTRA
Chapman Steven Leonard (CEO AND PRESIDENT) sold 3,801 shares of Natera, Inc. (NTRA) at an average of $411.80 ($387.90–$415.64, $1.57M total) across 3 trades on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale may cause short‑term price softness but is unlikely to drive a sustained move.
Market read
A modest insider sell by the CEO provides a small, actionable data point for short‑term traders.
What to watch
The CEO still holds a sizable position, and the sale was pre‑arranged under a 10b5‑1 plan.
Background
Form 4 filings disclose insider transactions; investors watch CEO sales for potential signals.
Ticker impact
CEO Steven Leonard sold 3,801 shares for $1.56M via a 10b5‑1 plan, reducing his stake to 87,431 shares.
likely downward pressure as the market prices in the insider sell
A $1.6M sale by the CEO is a material insider transaction, but the amount is modest relative to market cap, so impact is limited.
Market effects
Minimal; the sale does not affect the broader genetic testing sector.
None
Low
Counterpoint
The sale could be a routine liquidity event unrelated to company outlook.
Key entities
- personSteven Leonard
CEO and President of Natera, Inc.



